Non-cell autonomous disruption of genomic interactions as a cause of dementia
基因组相互作用的非细胞自主破坏是痴呆的原因
基本信息
- 批准号:10712217
- 负责人:
- 金额:$ 41.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAdministrative SupplementAfferent NeuronsAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAnosmiaArchitectureAutopsyCOVID-19ChemicalsDataDementiaDetectionDevelopmentDiseaseEventExhibitsFractionationFunctional disorderGenomicsHamstersHumanImpaired cognitionIn SituIndianaInflammatoryInflammatory ResponseLinkMediatingModelingMolecularMusMutationNasal EpitheliumNatureNerve DegenerationNeurodegenerative DisordersNeurogliaNeurologic SymptomsNeuronsNoseNuclearOdorsOlfactory EpitheliumOlfactory PathwaysOlfactory dysfunctionParkinson DiseasePatientsPatternPeripheralPopulationPropertyProteinsReceptor Down-RegulationReportingSARS-CoV-2 infectionSerumSignal PathwaySignal TransductionSmell PerceptionSortingSouth AfricanSymptomsTechniquesTestingVeinsVirus DiseasesWorkexperimental studyextracellularfamilial Alzheimer diseaseinducible Cremolecular diagnosticsmouse modelmutantnovelnovel diagnosticsnovel therapeuticsolfactory receptorolfactory sensory neuronsprognostic toolpromoterprotein aggregationprotein misfoldingreceptor downregulationreceptor expressionresponseskillstranscriptome sequencing
项目摘要
Summary/Abstract
Olfactory dysfunction is considered a prodrome syndrome of Alzheimer’s Disease (AD) and Dementia. Yet, the
molecular and cellular mechanisms that cause olfactory deficits in AD patients before the onset of cognitive
decline remain unknown. Here, we built upon our recent observations on the mechanisms of SARS-CoV-2
mediated anosmia to decipher how protein misfolding and aggregation in a small fraction of sensory neurons
can cause widespread deficits in odor detection by the olfactory system. Our studies on hamsters and humans,
revealed that interchromosomal genomic interactions required for olfactory receptor (OR) expression are
extremely fragile and dissipate rapidly in response to inflammatory signals elicited by SARS-CoV-2 infection.
Strikingly, similar disruption of nuclear architecture is revealed by our preliminary data in mouse models for AD
which also exhibit similar inflammatory signatures with the SARS-CoV-2 infected hamsters. Based on these
striking similarities between the two conditions, we propose to investigate the provocative premise that anosmia
in AD is caused by non-cell autonomous disruption of genomic OR compartments and, thus, OR downregulation.
We will experimentally test whether sporadic expression of human APP mutants linked to AD can change the
patterns of interchromosomal interactions of naive olfactory neurons, and we will explore if the serum of human
APP-expressing mice can alter the nuclear architecture of wild type neurons, mimicking our observations for
COVID-19. Finally, expanding on our recent skills in analyzing the nuclear architecture of olfactory neurons from
human autopsies, we will investigate whether similar changes are observed in human olfactory neurons of AD
patients. Our proposed experiments have the potential to uncover novel molecular and cellular mechanisms of
propagation of AD pathology, and to enable the development of molecular diagnostics that can predict whether
late onset olfactory dysfunction is a prodrome of AD.
总结/摘要
嗅觉功能障碍被认为是阿尔茨海默病(AD)和痴呆的前驱症状综合征。然而
AD患者在认知功能障碍发作前引起嗅觉障碍的分子和细胞机制
下降仍然未知。在这里,我们建立在我们最近对SARS-CoV-2机制的观察基础上,
介导的嗅觉丧失,以破译蛋白质如何错误折叠和聚集在一小部分感觉神经元
会导致嗅觉系统对气味的检测普遍不足。我们对仓鼠和人类的研究,
揭示了嗅觉受体(OR)表达所需的染色体间基因组相互作用,
在SARS-CoV-2感染引发的炎症信号的反应中,它们非常脆弱并迅速消散。
引人注目的是,我们在AD小鼠模型中的初步数据揭示了类似的核结构破坏
其也表现出与SARS-CoV-2感染的仓鼠相似的炎症特征。基于这些
这两种情况之间惊人的相似之处,我们建议调查的挑衅性前提,嗅觉丧失
在AD中,由基因组OR区室的非细胞自主破坏引起,因此,OR下调。
我们将通过实验测试与AD相关的人APP突变体的零星表达是否可以改变AD的发病机制。
幼稚嗅觉神经元的染色体间相互作用的模式,我们将探讨是否人的血清
表达APP的小鼠可以改变野生型神经元的核结构,模拟我们对
2019冠状病毒病。最后,扩展我们最近在分析嗅觉神经元核结构方面的技能,
人类尸检,我们将调查是否在AD的人类嗅觉神经元中观察到类似的变化
患者我们提出的实验有可能揭示新的分子和细胞机制,
传播AD病理,并使分子诊断的发展,可以预测是否
迟发性嗅觉功能障碍是AD的前驱症状。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stavros Lomvardas其他文献
Stavros Lomvardas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stavros Lomvardas', 18)}}的其他基金
The "olfactosome" as a biomolecular condensate
作为生物分子凝聚物的“嗅觉体”
- 批准号:
10669291 - 财政年份:2022
- 资助金额:
$ 41.12万 - 项目类别:
Olfactory receptor mRNAs as lncRNAs that regulate genomic interactions
嗅觉受体 mRNA 作为调节基因组相互作用的 lncRNA
- 批准号:
10376032 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Principles of zonal olfactory receptor gene expression
带状嗅觉受体基因表达原理
- 批准号:
10350605 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Interrogating genome folding trajectories in health and disease
探究健康和疾病中的基因组折叠轨迹
- 批准号:
10473744 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Olfactory receptor mRNAs as lncRNAs that regulate genomic interactions
嗅觉受体 mRNA 作为调节基因组相互作用的 lncRNA
- 批准号:
10614532 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Principles of zonal olfactory receptor gene expression
带状嗅觉受体基因表达原理
- 批准号:
10570848 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Interrogating genome folding trajectories in health and disease
探究健康和疾病中的基因组折叠轨迹
- 批准号:
10685554 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Deciphering mechanisms of COVID-19 induced anosmia
解读 COVID-19 引起的嗅觉丧失的机制
- 批准号:
10176800 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Interrogating genome folding trajectories in health and disease
探究健康和疾病中的基因组折叠轨迹
- 批准号:
10117398 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
Interrogating genome folding trajectories in health and disease
探究健康和疾病中的基因组折叠轨迹
- 批准号:
10266185 - 财政年份:2020
- 资助金额:
$ 41.12万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
- 批准号:
10893074 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:














{{item.name}}会员




